Christopher A. Van Tuyl's most recent trade in Immunovant Inc was a trade of 71,531 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunovant Inc | Christopher A. Van Tuyl | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 71,531 | 71,531 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Christopher A. Van Tuyl | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 50,787 | 160,743 (0%) | 0% | 0 | Common Stock | |
| Immunovant Inc | A. Christopher Van Tuyl | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2024 | 137,446 | 137,446 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | A. Van Tuyl Christopher | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2024 | 109,956 | 109,956 (0%) | 0% | 0 | Common Stock |